期刊文献+

Dangfei Liganning Capsules (当飞利肝宁胶囊) Attenuate the Susceptibility of Rat Nonalcoholic Fatty Liver to Carbon Tetrachloride Toxicity 被引量:15

Dangfei Liganning Capsules (当飞利肝宁胶囊) Attenuate the Susceptibility of Rat Nonalcoholic Fatty Liver to Carbon Tetrachloride Toxicity
原文传递
导出
摘要 Objective: To test whether nonalcoholic hepatic steatosis sensitizes carbon tetrachloride (CCl4)-induced liver injury, and to assess the therapeutic effect of Chinese medicine extracts of Dangfei Liganning capsules (当飞利肝宁胶囊) and their potential underlying mechanisms. Methods: Male Wistar rats were fed a high-fat diet to induce nonalcoholic fatty liver disease (NAFLD) or a normal diet (N). Eight weeks later, a nonlethal dose of CCl4 was applied intraperitoneally. From the start, HF-CCl4 rats were administered daily Dangyao extracts (D), Dangfei Liganning capsules (DF), or Diammonium Glycyrrhizinate (G) intragastrically. Rats were sacrificed 48 h after CCl4 administration. In addition to serum biochemistry, liver histopathology was observed using hematoxylin-eosin (HE) and oil red O staining, and hepatic levels of triglyceride (TG), malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), caspase-3 activation and cytochrome P450 (CYP2E1) expression were assessed. Results: There was almost no response to the nonlethal dose of CCl4 in the N control group. However, the HF group demonstrated massive steatosis, and elevated levels of serum ALT and AST, liver MDA, CYP2E1, and caspase-3 activation, whereas the levels of GSH and SOD were significantly decreased. All indexes assessed were dramatically worse in the HF-CCl4 group compared to the HF group, in addition to the more severe steatosis, hepatocyte ballooning, and inflammatory infiltration apparent in the centrilobular area. The medicines we tested affected the pathological changes in HF-CCl4 rats to differing degrees: DF and G led to improvements in all of the above examined indexes, including an obvious improvement in histopathology, and DF improved serum ALT and MDA levels more markedly than G, whereas D extracts produced only mild liver injury attenuation. Conclusion: Liver with NAFLD is more sensitive to hepatotoxicity; furthermore, the disrupted balance of oxidative stress and anti-oxidant defense contributes to the underlying mechanisms. Dangfei Liganning capsules potentially decrease this toxic susceptibility and alleviate liver injury in non-alcoholic fatty liver. Objective: To test whether nonalcoholic hepatic steatosis sensitizes carbon tetrachloride (CCl4)-induced liver injury, and to assess the therapeutic effect of Chinese medicine extracts of Dangfei Liganning capsules (当飞利肝宁胶囊) and their potential underlying mechanisms. Methods: Male Wistar rats were fed a high-fat diet to induce nonalcoholic fatty liver disease (NAFLD) or a normal diet (N). Eight weeks later, a nonlethal dose of CCl4 was applied intraperitoneally. From the start, HF-CCl4 rats were administered daily Dangyao extracts (D), Dangfei Liganning capsules (DF), or Diammonium Glycyrrhizinate (G) intragastrically. Rats were sacrificed 48 h after CCl4 administration. In addition to serum biochemistry, liver histopathology was observed using hematoxylin-eosin (HE) and oil red O staining, and hepatic levels of triglyceride (TG), malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), caspase-3 activation and cytochrome P450 (CYP2E1) expression were assessed. Results: There was almost no response to the nonlethal dose of CCl4 in the N control group. However, the HF group demonstrated massive steatosis, and elevated levels of serum ALT and AST, liver MDA, CYP2E1, and caspase-3 activation, whereas the levels of GSH and SOD were significantly decreased. All indexes assessed were dramatically worse in the HF-CCl4 group compared to the HF group, in addition to the more severe steatosis, hepatocyte ballooning, and inflammatory infiltration apparent in the centrilobular area. The medicines we tested affected the pathological changes in HF-CCl4 rats to differing degrees: DF and G led to improvements in all of the above examined indexes, including an obvious improvement in histopathology, and DF improved serum ALT and MDA levels more markedly than G, whereas D extracts produced only mild liver injury attenuation. Conclusion: Liver with NAFLD is more sensitive to hepatotoxicity; furthermore, the disrupted balance of oxidative stress and anti-oxidant defense contributes to the underlying mechanisms. Dangfei Liganning capsules potentially decrease this toxic susceptibility and alleviate liver injury in non-alcoholic fatty liver.
出处 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2011年第4期327-333,共7页 中医杂志(英文版)
基金 supported by the National Natural Science Foundation of China (30872360) Leading Academic Discipline Project and Innovative Research Team in Universities, Shanghai Municipal Education Commission (J50305) Natural Science Foundation of Shanghai (11ZR1436900)
关键词 NAFLD liver injury CCl4 Dangfei Liganning capsules oxidative stress Wistar大鼠 四氯化碳 脂肪肝 酒精性 敏感性 胶囊 caspase-3 细胞色素P450
  • 相关文献

参考文献25

  • 1宋毅,刘培曦.当飞利肝宁防治抗结核药致肝损害的效果观察[J].中国现代药物应用,2011,5(3):13-14. 被引量:4
  • 2黄欣,张哲永.当飞利肝宁胶囊治疗非酒精性脂肪性肝病32例临床观察[J].中医杂志,2007,48(6):524-525. 被引量:23
  • 3Jeffrey R. Lewis,Smruti R. Mohanty.Nonalcoholic Fatty Liver Disease: A Review and Update[J]. Digestive Diseases and Sciences . 2010 (3)
  • 4Kucera O,Lotkova H,Stankova P,Podhola M,Rousar T,Mezera V, et al.Is rat liver affected by non-alcoholic steatosis more susceptible to the acute toxic effect of thioacetamide?. International Journal of Experimental Pathology . 2011
  • 5Tarantino G,Conca P,Basile V,Gentile A,Capone D,Polichetti G, et al.A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatology Research . 2007
  • 6Koek GH,Liedorp PR,Bast A.The role of oxidative stress in non-alcoholic steatohepatitis. Clinica Chimica Acta . 2011
  • 7Wang Y,Ausman LM,Russell RM,Greenberg AS,Wang XD.Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. The Journal of Nutrition . 2008
  • 8Ding BY.A Clinical Observation on Dangfei Liganning Capsules for 45 Cases of Chrocic Hepatitis B. Journal of Traditional Chinese Medicine . 2009
  • 9Ma HJ.A Clinical Observation on Dangfei Liganning Capsules for 50 Cases of Chrocic Hepatitis B with fibrosis. Journal of Traditional Chinese Medicine . 2009
  • 10Zhao H,Chen WP,Jiang LY.Impact of Dangfei Liganning Capsules on anti-oxidant system of Chrocic Hepatitis B patients. Journal of Traditional Chinese Medicine . 2007

二级参考文献11

共引文献24

同被引文献185

引证文献15

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部